Get the Stockscreener App
0.71
2.31%
0.016
Pre-market:
.71
Dariohealth Corp stock is traded at $0.71, with a volume of 1.14M.
It is up +2.31% in the last 24 hours and down -11.25% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.694
Open:
$0.76
24h Volume:
1.14M
Relative Volume:
2.39
Market Cap:
$27.26M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.6893
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
+2.60%
1M Performance:
-11.25%
6M Performance:
-40.83%
1Y Performance:
-69.13%
1-Day Range:
$0.6708
$0.76
1-Week Range:
$0.65
$0.81
52-Week Range:
$0.631
$2.60
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.71 | 27.26M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy - MSN
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PR Newswire
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth Corp (DRIO): AI Solutions for Health and Wellness - Insider Monkey
DRIODarioHealth Corp. Latest Stock News & Market Updates - StockTitan
DarioHealth Expands Weight Loss Platform With GLP-1 Prescriptions as Stock Surges 14% - StockTitan
DarioHealth Partners With MediOrbis to Launch Comprehensive GLP-1 Weight Loss Program - StockTitan
DarioHealth Corp. announced that it expects to receive $6.824 million in funding - Marketscreener.com
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update - Defense World
DarioHealth stock hits 52-week low at $0.64 amid market challenges - Investing.com
DarioHealth stock hits 52-week low at $0.64 amid market challenges By Investing.com - Investing.com South Africa
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges By Investing.com - Investing.com South Africa
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges - Investing.com Canada
DarioHealth Corp confirms new board, ratifies auditors - Investing.com India
DarioHealth Corp confirms new board, ratifies auditors By Investing.com - Investing.com UK
Dario Signs Four New Employer Contracts Across Full Product Suite - The Eastern Progress Online
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges - Investing.com Canada
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges By Investing.com - Investing.com South Africa
Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition Platform - The Eastern Progress Online
DarioHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
DarioHealth stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada
/C O R R E C T I O N -- DarioHealth Corp./ - GuruFocus.com
DarioHealth to Report Third Quarter 2024 Results on Thursday, No - GuruFocus.com
Twill by Dario to Offer a Benefit for AARP Members - GuruFocus.com
National Medicare Health Plan Partners with Twill by Dario to Pr - GuruFocus.com
DarioHealth secures four new employer contracts for 2025 By Investing.com - Investing.com Canada
DarioHealth secures four new employer contracts for 2025 - Investing.com India
DarioHealth Corp. Signs Four New Employer Contracts Across Full Product Suite - Marketscreener.com
Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch - Simply Wall St
DarioHealth Corp. (NASDAQ:DRIO) Q3 2024 Earnings Call Transcript - Insider Monkey
DarioHealth Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
DarioHealth Corp (DRIO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
WELL Health reports record revenue of $251.7M in Q3 2024 and more digital health earnings - Mobihealth News
DarioHealth Earnings Reflect Growth Amid Challenges - TipRanks
DarioHealth Corp. (DRIO) Quarterly 10-Q Report - Quartzy
DarioHealth Reports Third Quarter 2024 Financial and Operating Results - citybiz
DarioHealth earnings beat by $0.47, revenue topped estimates - Investing.com
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
DarioHealth teams up with pharma company to boost user engagement - Mobihealth News
Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement - StockTitan
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population - IT News Online
DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th - IT News Online
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.02%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):